Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

gastrointestinal · Mechanism Report

Can intestinal dysbiosis and bacterial overgrowth cause bloating and malabsorption?

Intestinal dysbiosis, particularly SIBO, drives bloating and contributes to malabsorption via excess fermentation, mucosal injury, and altered bile acid metabolism.

SupportedJune 19, 202622 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Intestinal dysbiosis and bacterial overgrowth can drive bloating and contribute to malabsorption by injuring the mucosa and altering bile acid metabolism needed for fat absorption.

laying out figure…
All 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that bacterial overgrowth in the small intestine produces gases that distend the lumen causing bloating, and that overgrowth injures enterocytes and reduces brush-border enzymes, impairing nutrient uptake. It also frames a mechanism in which bacterial bile salt hydrolase activity deconjugates bile acids, preventing micelle formation and leading to fat malabsorption.

Verified conclusion

Intestinal dysbiosis, particularly Small Intestinal Bacterial Overgrowth (SIBO), is a well-documented driver of gastrointestinal distress and nutrient malabsorption through multiple synergistic pathways.

Clinical and mechanistic findings on bloating

Bloating is primarily driven by the excessive fermentation of carbohydrates by an overgrowth of bacteria or methanogens in the small intestine.

  • Gas Production: Organisms such as Archaea or colonic-type bacteria ferment undigested dietary fibers and sugars, producing hydrogen (H₂), methane (CH₄), and hydrogen sulfide (H₂S) gases.
  • Luminal Distension: The resulting gas leads to physical distension of the intestinal lumen, which is perceived as bloating. Methane production is specifically linked to delayed transit and constipation, further exacerbating the sensation of fullness.
  • Therapeutic Evidence: Clinical trials demonstrate that reducing bacterial load with non-absorbable antibiotics like rifaximin significantly alleviates these symptoms.

Impact on mucosal integrity and malabsorption

Dysbiosis contributes to malabsorption by physically and enzymatically damaging the intestinal lining.

  • Structural Damage: Bacterial toxins and inflammatory byproducts cause direct injury to enterocytes, leading to villous blunting or shortening. This reduction in the intestinal surface area significantly decreases the capacity for nutrient uptake.
  • Enzymatic Deficiency: Damage to the brush border reduces the activity of essential digestive enzymes, such as lactase and peptidases, hindering the breakdown of carbohydrates and proteins.
  • Leaky Gut: Chronic overgrowth triggers low-grade inflammation and increased intestinal permeability, which further disrupts normal metabolic and absorptive functions.

Alteration of bile acid metabolism

A critical mechanism for fat malabsorption in dysbiosis involves the premature breakdown of bile salts.

  • Bile Deconjugation: Bacteria such as Bacteroides and Clostridium produce bile salt hydrolase (BSH) enzymes. These enzymes deconjugate primary bile acids (e.g., cholic acid) before they can fulfill their role in digestion.
  • Impaired Micelle Formation: Deconjugated bile acids are less soluble and cannot effectively form micelles, which are necessary to emulsify dietary fats. Without micelle formation, pancreatic lipases cannot adequately break down fats for absorption.
  • Steatorrhea: This disruption leads to fat malabsorption, often manifesting clinically as steatorrhea (fatty stools) and deficiencies in fat-soluble vitamins (A, D, E, and K).

Bottom line

The claim is strongly supported by scientific evidence. Intestinal dysbiosis drives bloating via gas-producing fermentation and causes malabsorption through both direct mucosal injury and the enzymatic deconjugation of bile acids, which prevents proper fat emulsification and absorption.

References

  1. HOLISTIC APPROACHES TO SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO): A REVIEW OF DIAGNOSTIC TOOLS AND COMBINED THERAPEUTIC STRATEGIES — rsglobal.pl ↗
  2. IBS and SIBO: Gut Microbiota, Pathophysiology, and Non-Pharmacological Interventions — mdpi.com ↗
  3. Dysbiosis and nutrition in steatotic liver disease: addressing the unrecognized small intestinal bacterial overgrowth (SIBO) challenge — link.springer.com ↗
  4. Small intestinal bacterial overgrowth: a comprehensive review. — pmc.ncbi.nlm.nih.gov ↗
  5. The prevalence of intestinal dysbiosis in patients referred for antireflux surgery — link.springer.com ↗
  6. Aetiology, diagnosis and management of small intestinal bacterial overgrowth — pmc.ncbi.nlm.nih.gov ↗
  7. Small Intestinal Bacterial Overgrowth, Pathophysiology and its implications for Definition and Management. — linkinghub.elsevier.com ↗
  8. The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders — pmc.ncbi.nlm.nih.gov ↗
  9. Methane, Bacteria, Fungi, and Fermentation: Pathophysiology, Diagnosis and Treatment Strategies for Small Intestinal Bacterial Overgrowth, Intestinal Methanogen Overgrowth and Small Intestinal Fungal Overgrowth — mdpi.com ↗
  10. [Small intestinal bacterial overgrowth in gastrointestinal diseases - a consequence or a cause of progression?] — voprosy-pitaniya.ru ↗
  11. Diagnostic Challenges in Enteropathies: A Histopathological Review — mdpi.com ↗
  12. Association between Gut Dysbiosis and the Occurrence of SIBO, LIBO, SIFO and IMO — pmc.ncbi.nlm.nih.gov ↗
  13. European Consensus on Malabsorption—UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN. Part 1: Definitions, Clinical Phenotypes, and Diagnostic Testing for Malabsorption — pmc.ncbi.nlm.nih.gov ↗
  14. Lead promoted bile acid deconjugation by modulating gut bacteria encoding bile salt hydrolase (BSH) in Rana chensinensis tadpoles. — linkinghub.elsevier.com ↗
  15. Bile acid and its bidirectional interactions with gut microbiota: a review — tandfonline.com ↗
  16. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome — pnas.org ↗
  17. Improved annotation of conjugated bile acid hydrolase superfamily members in Gram-positive bacteria. — microbiologyresearch.org ↗
  18. Preservation of conjugated primary bile acids by oxygenation of the small intestinal microbiota in vitro — journals.asm.org ↗
  19. Preservation of conjugated primary bile acids by oxygenation of the small intestinal microbiota in vitro — pmc.ncbi.nlm.nih.gov ↗
  20. Bile salt hydrolases: Gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract — pmc.ncbi.nlm.nih.gov ↗
  21. Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis — pmc.ncbi.nlm.nih.gov ↗
  22. Gut microbiota‐associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice — academic.oup.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Unsupported12 sourcesCan reflux reaching the larynx and pharynx irritate upper-airway mucosa and relate to chronic rhinosinusitis?→Plausible11 sourcesDoes BabA-positive Helicobacter pylori bind gastric epithelial Lewis b antigens and promote inflammation?→